Octavia Cadassou

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Identification of specific oncogenic gene changes has enabled the modern generation of targeted cancer therapeutics. In high-grade serous ovarian cancer (OV), the bulk of genetic changes is not somatic point mutations, but rather somatic copy-number alterations (SCNAs). The impact of SCNAs on tumour biology remains poorly understood. Here we build(More)
  • 1